Back to User profile » Professor Shigeru Honda
Papers published by Professor Shigeru Honda:
Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
Takahashi K, Ohji M, Terasaki H, Honda S, Margaron P, Guerin T, Yuzawa M
Clinical Ophthalmology 2018, 12:1789-1799
Published Date: 13 September 2018
Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion
Hirose M, Matsumiya W, Honda S, Nakamura M
Clinical Ophthalmology 2014, 8:2301-2305
Published Date: 19 November 2014
Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size
Nishimura Y, Taguchi M, Nagai T, Fujihara M, Honda S, Uenishi M
Clinical Ophthalmology 2012, 6:365-368
Published Date: 6 March 2012
Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation
Nakano S, Honda S, Oh H, Kita M, Negi A
Clinical Ophthalmology 2012, 6:277-282
Published Date: 20 February 2012
VEGF 936C>T is predictive of threshold retinopathy of prematurity in Japanese infants with a 30-week gestational age or less
Mariko Yagi, Motohiro Yamamori, Ichiro Morioka, et al
Research and Reports in Neonatology 2011, 1:5-11
Published Date: 3 March 2011